Monthly Archives: August 2021

Personalized regenerative medicine company developing implanted cell pockets to treat chronic diseases

Crystal Nyitray, Ph.D., CEO and Co-Founder of Encellin provided an overview of the company’s emerging cellular technology to treat chronic endocrine disorders, hypoglycemia and hypocalcemia. Why did you start this business? Encellin was founded because we have a unique opportunity to help millions of patients. The technology developed at UCSF …

Read More »